You are here

  • Home
  • Archive
  • Volume 77, Issue Suppl 2
  • OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors

Citation Tools

Article menu

Download PDFPDF

WEDNESDAY, 13 JUNE 2018
Doctor, how bad will my rheumatoid become? RA – prognosis, predictors and outcomes
OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Brahe C, Krabbe S, Østergaard M, et al
OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors
Annals of the Rheumatic Diseases 2018;77:70-71.